Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  NeuroReport

• Publication date

  1999-11-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00001756-199911260-00039PMID 10619665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of hyperthermia in the protective action of clomethiazole against MDMA (‘ecstasy’)‐induced neurodegeneration, comparison with the novel NMDA channel blocker AR‐R15896AR

  1998cited by this paper
• Redox regulation of cell functions by alpha-lipoate: biochemical and molecular aspects.

  1998cited by this paper
• Redox regulation of cell functions by α‐lipoate: biochemical and molecular aspects

  1998cited by this paper
• The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

  1998cited by this paper
• Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat

  1998cited by this paper
• An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.

  1998cited by this paper
• Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid

  1997cited by this paper
• Neuroprotection by the metabolic antioxidant alpha-lipoic acid.

  1997cited by this paper
• In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not the degeneration following fenfluramine

  1997cited by this paper
• The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.

  1996cited by this paper
• Brain Temperature Alters Hydroxyl Radical Production during Cerebral Ischemia/Reperfusion in Rats

  1996cited by this paper
• Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

  1996cited by this paper
• Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptor.

  1995cited by this paper
• The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine

  1995cited by this paper
• Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.

  1995cited by this paper
• The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.

  1995cited by this paper
• Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid.

  1995cited by this paper
• Detection of Free Radical Activity During Transient Global Ischemia and Recirculation: Effects of Intraischemic Brain Temperature Modulation

  1995cited by this paper
• Excitatory amino acids as a final common pathway for neurologic disorders.

  1994cited by this paper
• Quantitative Features of Reactive Gliosis following Toxicant‐induced Damage of the CNS a

  1993cited by this paper
• Quantitative aspects of reactive gliosis: A review

  1992cited by this paper
• Glial changes following an excitotoxic lesion in the CNS--II. Astrocytes.

  1991cited by this paper
• Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset.

  1991cited by this paper
• Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.

  1990cited by this paper
• Characterization of [3H]Paroxetine Binding in Rat Brain

  1988cited by this paper
• 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.

  1987cited by this paper
• Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals.

  1981cited by this paper

• Psychedelic Therapy: A Primer for Primary Care Clinicians—3,4-Methylenedioxy-methamphetamine (MDMA)

  2024cites this paper
• Curcumin can improve ecstasy-induced hippocampal damage in rat

  2023cites this paper
• MDMA administration attenuates hippocampal IL-β immunoreactivity and subsequent stress-enhanced fear learning: An animal model of PTSD

  2022cites this paper
• Effect of MDMA exposure during pregnancy on cell apoptosis, astroglia, and microglia activity in rat offspring striatum

  2022cites this paper
• Exogenous Ghrelin Could Not Ameliorate 3,4-methylenedioxymethamphetamine-induced Acute Liver Injury in The Rat: Involved Mechanisms

  2020cites this paper
• Drugs on the internet: Mapping the terrain of engagement with darknet drug cryptomarkets in New Zealand

  2019cites this paper
• Ghrelin Alleviates MDMA-Induced Disturbance of Serum Glucose and Lipids Levels in the Rat.

  2017cites this paper
• Amphetamine‐related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

  2017cites this paper
• Influence of different neuroprotective drugs on dopamine neurotoxicity induced by 3,4-methylenedioxymethamphetamine and MPTP in mice

  2016cites this paper
• MDMA and Glutamate: Implications for Hippocampal GABAergic Neurotoxicity

  2016cites this paper
• Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.

  2015cites this paper
• 3,4-methylenedioxy-methamphetamine(MDMA)-induced increases in hippocampal glutamate concentrations and its impact on the dentate gyrus

  2015cites this paper
• Effect of alpha lipoic acid on ifosfamide-induced central neurotoxicity in rats

  2014cites this paper
• Nuevas drogas psicoestimulantes. Estudio farmacológico y neurotoxicológico de la metilona

  2014cites this paper
• Efeitos da exposição à amônia em células astrogliais e neuronais : mecanismos protetores do resveratrol e do ácido lipoico

  2014cites this paper
• Effects of MDMA on the Human Nervous System

  2014cites this paper
• Inhibition of Cyclic Nucleotide Phosphodiesterases to Regulate Memory

  2014cites this paper
• Glial cell response to 3,4-(+/-)-methylenedioxymethamphetamine and its metabolites.

  2014influential citation
• Alpha-lipoic acid effects on brain glial functions accompanying double-stranded RNA antiviral and inflammatory signaling.

  2014cites this paper
• Dottorato di Ricerca in Tossicologia - Indirizzo Farmacologia e Farmacoterapia delle Tossicodipendenze Ciclo XXVI

  2013cites this paper
• Chronic and Sub-acute Effects of 3,4-methylenedioxy methamphetamine (MDMA) on Spatial Memory and Passive Avoidance Learning in Wistar Rats

  2013cites this paper
• Methylenedioxymethamphetamine-induced neurotoxicity: The role of hepatic enzymes cytochrome p450 2d6 and catechol-o-methyltransferase and contribution of microglia

  2013cites this paper
• Effects of Repeated Administration of 3,4-methylenedioxymethamphetamine (MDMA) on Avoidance Memory and Cell Density in Rats’ Hippocampus

  2013cites this paper
• 3,4-Methylenedioxymethamphetamine Induces Gene Expression Changes in Rats Related to Serotonergic and Dopaminergic Systems, But Not to Neurotoxicity

  2013cites this paper
• Lipoic acid increases glutamate uptake, glutamine synthetase activity and glutathione content in C6 astrocyte cell line

  2013cites this paper
• Lipoic acid protects C6 cells against ammonia exposure through Na⁺-K⁺-Cl⁻ co-transporter and PKC pathway.

  2013cites this paper
• Elucidating the Cellular Effects of MDMA on the Serotonin Transporter (SERT)

  2012cites this paper
• Modulatory effects of vitamin E, acetyl-L-carnitine and α-lipoic acid on new potential biomarkers for Alzheimer's disease in rat model.

  2012cites this paper
• Safrole oxide induced neuronal differentiation of rat bone-marrow mesenchymal stem cells by elevating Hsp70.

  2012cites this paper
• Possible Mechanisms for the Role of Dietary Supplements in Management of Alzheimer ’ s Disease in Aged Rats

  2011cites this paper
• Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation

  2011cites this paper
• Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat

  2011cites this paper
• Ultrastructural characterization of tryptophan hydroxylase 2-specific cortical serotonergic fibers and dorsal raphe neuronal cell bodies after MDMA treatment in rat

  2011cites this paper
• Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity

  2011cites this paper
• Role of Neuropeptide Y in Depression: Current Status

  2011cites this paper
• The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis

  2011cites this paper
• Selenoproteins and Brain Diseases

  2011cites this paper
• Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity

  2010cites this paper
• MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain.

  2010cites this paper
• Neurotoxicidade da "Ectasy" e dos seus metabolitos em células humanas dopaminérgicas SH-SY5Y

  2010cites this paper
• Effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity

  2010cites this paper
• MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings.

  2010cites this paper
• The health and psychological effects of "ecstasy" (MDMA) use

  2010cites this paper
• Efectos conductuales y neuroquímicos del consumo de éxtasis y cocaína en ratones adolescentes.

  2009cites this paper
• On the Mechanisms Underlying 3,4-Methylenedioxymethamphetamine Toxicity: The Dilemma of the Chicken and the Egg

  2009cites this paper
• Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview

  2009cites this paper
• Metabolites of MDMA Induce Oxidative Stress and Contractile Dysfunction in Adult Rat Left Ventricular Myocytes

  2009cites this paper
• Investigations into the potential for 3,4-methylenedioxymethamphetamine to induce neurotoxic terminal damage to serotonergic neurons

  2009cites this paper
• Phosphodiesterase 5 inhibitors prevent 3,4‐methylenedioxymethamphetamine‐induced 5‐HT deficits in the rat

  2009cites this paper
• Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines

  2008cites this paper
• The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity

  2008cites this paper
• Developmental effects of 3,4-methylenedioxymethamphetamine: a review

  2008cites this paper
• Stimulerende middelen: xtc

  2008cites this paper
• Ecstasy produces left ventricular dysfunction and oxidative stress in rats.

  2008cites this paper
• Minoxidil prevents 3,4‐methylenedioxymethamphetamine‐induced serotonin depletions: role of mitochondrial ATP‐sensitive potassium channels, Akt and ERK

  2008cites this paper
• On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats.

  2008cites this paper
• Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.

  2007cites this paper
• MDMA and Other “Club Drugs”

  2007cites this paper
• Oxidative Stress in Rat Retina and Hippocampus after Chronic MDMA (‘ecstasy’) Administration

  2007cites this paper
• The effect of amphetamine analogs on cleaved microtubule-associated protein-tau formation in the rat brain.

  2007cites this paper
• Synthesis and antitumour evaluation of peptidyl-like derivatives containing the 1,3-benzodioxole system.

  2007cites this paper
• In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p‐methoxyamphetamine (PMA), but not 3,4‐methylenedioxymethamphetamine (MDMA), leads to long‐lasting deficits in serotonin transporter function

  2007cites this paper
• Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.

  2007cites this paper
• Induction of heat shock proteins may combat insulin resistance.

  2006cites this paper
• Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines

  2006cites this paper
• 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

  2006cites this paper
• Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions

  2006cites this paper
• Neuroimaging research in human MDMA users: a review

  2006cites this paper
• Binge administration of 3,4-methylenedioxymethamphetamine ("ecstasy") impairs the survival of neural precursors in adult rat dentate gyrus.

  2006cites this paper
• Patterns of use and harm reduction practices of ecstasy users in Australia.

  2006cites this paper
• Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: Temporal, spatial, and cellular patterns

  2006cites this paper
• Safrole oxide induced human umbilical vein vascular endothelial cell differentiation into neuron-like cells by depressing the reactive oxygen species level at the low concentration.

  2006cites this paper
• Zur Neurotoxizität von Methylendioxyamphetaminen (Ecstasy) : akustisch evozierte Potentiale als Mass für das Funktionsniveau serotonerger Neuronenverbände im ZNS

  2006cites this paper
• (±)-3,4-Methylenedioxymethamphetamine Administration to Rats Does Not Decrease Levels of the Serotonin Transporter Protein or Alter Its Distribution between Endosomes and the Plasma Membrane

  2005cites this paper
• Effect of acute and chronic psychostimulant drugs on redox status, AP-1 activation and pro-enkephalin mRNA in the human astrocyte-like U373 MG cells.

  2005cites this paper
• ¿Qué quieren saber los usuarios de éxtasis?: estudio de una lista de correo de Internet

  2005cites this paper
• Chronic gliosis induced by loss of S-100B: knockout mice have enhanced GFAP-immunoreactivity but blunted response to a serotonin challenge.

  2005cites this paper
• The α2-adrenoceptor antagonist yohimbine reduces glial fibrillary acidic protein upregulation induced by chronic morphine administration

  2005cites this paper
• Safrole oxide inhibits angiogenesis by inducing apoptosis.

  2005cites this paper
• (r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia

  2004cites this paper
• Long-term consequences of ecstasy abuse: towards understanding the role of individual variation

  2004cites this paper
• Monitoring Drug‐Induced Neurodegeneration by Imaging of Peripheral Benzodiazepine Receptors

  2004cites this paper
• 3,4‐methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein

  2004cites this paper
• Advances in neuroprotection research for neurodegenerative diseases.

  2004cites this paper
• Effects of novel safrole oxide derivatives, 1-propyl-3-(3,4-methylenedioxyphenyl)-2-propanol and 1-isopropoxy-3-(3,4-methylenedioxyphenyl)-2-propanol, on apoptosis induced by deprivation of survival factors in vascular endothelial cells.

  2004cites this paper
• Effects of novel safrole oxide derivatives, 1-methoxy-3-(3,4-methylenedioxyphenyl)-2-propanol and 1-ethoxy-3-(3,4-methylenedioxyphenyl)-2-propanol, on apoptosis induced by deprivation of survival factors in vascular endothelial cells.

  2003cites this paper
• 3,4-Methylenedioxymethamphetamine (MDMA) Abuse may Cause Oxidative Stress and Potential Free Radical Damage

  2003cites this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003cites this paper
• Protective effect of green tea polyphenol (‐)‐epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates

  2003cites this paper
• 3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage.

  2003cites this paper
• Neurotoxische Langzeitschäden bei Ecstasy (MDMA)-KonsumentenÜberblick über den aktuellen Wissensstand

  2002cites this paper
• [Chronic neurotoxic damage in ecstasy (MDMA) users. Review of the current state of research].

  2002cites this paper
• Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy.

  2002cites this paper
• Preventing Problems in Ecstasy Users: Reduce Use to Reduce Harm

  2002cites this paper
• Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4‐methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats

  2002cites this paper
• α-lipoic acid protects the retina against ischemia-reperfusion

  2002cites this paper
• Alpha-lipoic acid prevents ethanol-induced protein oxidation in mouse hippocampal HT22 cells.

  2002cites this paper
• The health effects of ecstasy: a literature review.

  2002cites this paper
• Analysis of Ecstasy (MDMA)‐induced transcriptional responses in the rat cortex

  2002cites this paper
• How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

  2002cites this paper